Recent

% | $
Quotes you view appear here for quick access.

Johnson & Johnson Message Board

  • price_of_oil price_of_oil Mar 18, 2010 6:34 PM Flag

    JNJ losing pharma customers?

    I do not work for JNJ pharma, but was talking to a GYN surgeon today. He told me he will never again write a prescription for JNJ's Ortho Novum (spelling?) division. Here's why. Apparently that division cut out all the sales reps. He had previously depended on his rep to update him on new indications, contraindications, new products, etc. The rep also inventoried the birth control pill samples in his office and ordered additional stock as needed.
    The surgeon said now JNJ Ortho sends him a 30 minute CD, which he is not going to listen to. He would previously spend 5 minutes with the rep, get the info he needed, get his specific questions answered, and get back to his patients. He also said the procedure for getting samples is that someone in his office has to inventory the stock and write up and fax in an order. The first time this was done, he got no response for 2 weeks, so he had his office staff fax it in again. Then, he got a letter in the mail from JNJ Ortho saying he double ordered his samples, so they were canceling both orders!
    He said other birth control pill companies still supply the education, reps, and service he needs, so he will simply no longer write any prescriptions for JNJ Ortho. Has anyone else heard stories like this?

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • The OC market is generic. JNJ has been exiting this market over the last 5 years, gradually reducing sales representatives. (thus expenses)

      Ortho Evra and Ortho Tri Cyclen LO are the two products that are left in this arena. There comes a time when you exit markets and the time has come in OC's.

      Good management decision...

      • 1 Reply to redistributewealth
      • If my Dr were as childish and lazy as this one I would leave him!!. Imagine, he would stop writing scripts for medications (at the potential negative to the patient) because his lazy attitude towards inventory control in his office and no face to face contact.???
        My guess is he did very little business with JNJ and they just didn't see the value in HIM.

        This is a great company and the stock is getting ready to break out here.

 
JNJ
115.63-1.75(-1.49%)Jun 24 4:01 PMEDT